LAURA MCKASKLE: Open Payments
NPI 1902534837 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 40 payments from 15 companies in 2025. Trend: 2023 $127 · 2024 $520 · 2025 $873
Food & beverage: $783Education: $90
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 4 | $175 |
| GlaxoSmithKline, LLC. | 10 | $159 |
| GENZYME CORPORATION | 2 | $67 |
| Verona Pharma, Inc. | 3 | $65 |
| Philips North America LLC | 4 | $59 |
| Actelion Pharmaceuticals US, Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Amgen Inc. | 2 | $43 |
| Insmed, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: XYWAV, NUCALA, DUPIXENT, TEZSPIRE, Ohtuvayre, Vest Therapy Und, OPSUMIT, Arikayce.
Industry payments across FL — which companies pay providers there.
